Casa vira depósito de lixo e é motivo de briga entre irmãos em Divinópolis, MG

Criação de porcos também é motivo de reclamação.
O caso corre agora na justiça.

Anna Lúcia Silva Do G1 Triângulo Mineiro

Comente agora

Casa vira depósito de lixo em Divinópolis
(Foto: Anna Lúcia/G1)

Uma casa tem sido motivo de briga entre dois irmãos há mais de dez anos no Bairro Icaraí em Divinópolis, no Centro-Oeste do estado. O caminhoneiro Nelson Gomes Maia mora no local há quase 40 anos e, segundo ele, a residência vizinha, que pertence ao irmão dele, o aposentado José Maia Sobrinho, virou um depósito de lixo, além de haver uma criação de porcos. Ainda de acordo com Nelson, o local  tem atraído baratas, aranhas e ratos, além do mau cheiro.
Nelson disse que a Zoonoses da cidade já foi notificada, mas não resolveu o problema. “Os fiscais já foram à casa, notificaram, aplicaram multa, mas ele não pagou. Eu pago meus impostos e queria o cumprimento dos meus direitos. Além disso, essa situação está prejudicando a vizinhança e colocando a saúde de todos em risco”, disse o caminhoneiro.
Nelson contou ainda que cortou relacionamento com o irmão por causa do lixo e do chiqueiro no quintal. “Mesmo sendo meu irmão, seja quem for, não somos obrigados a tolerar mau cheiro nem as baratas e ratos. Já tivemos uma briga feia por causa disso. O chiqueiro incomoda até para almoçar, ele tem quatro porcos, galinhas, cachorros e muito lixo. Ele não mora na casa, ela serve simplismente para acumular lixo”.
O proprietário confirmou que já foi notificado e multado e que não irá retirar os animais. “Eu não vou tirar os meus porcos de lá e nem pagar a multa", afirmou José. Segundo Nelson, vários órgãos já foram procurados. "As autoridades não tomam providência, já procurei o Ibama, a Secretaria de Meio Ambiente e a Secretaria de Saúde", contou. O G1 entrou em contato com esss órgãos para saber como irão proceder neste caso.

Vizinho também reclama da criação de porcos no local (Foto: Anna Lúcia/G1)

Ibama
O Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renováveis (Ibama) em Uberlândia, no Triângulo Mineiro, informou que não é de competência do órgão cuidar de animais domésticos e que ele se destina exclusivamente a animais silvestres. “Essa parte compete aos órgãos municipais, trata-se se de um perímetro urbano, logo, não é um problema do Ibama”, explicou o chefe do setor regional do órgão, Aluísio Romar.
Secretaria de Meio Ambiente
De acordo com o gerente de fiscalização ambiental, da Secretaria de Meio Ambiente de Divinópolis, Francisco Faria, a secretaria já foi notificada, mas o caso corre em processo judicial porque não conseguiram encerrá-lo através de notificação, pois o dono da casa não quitou as multas aplicadas. O Ministério Público informou que não vai se pronunciar sobre o caso.
Secretaria de saúde
De acordo com a diretora da Vigilância em Saúde de Divinópolis, Adriana Gomes, este é um caso recorrente e o órgão já tomou as medidas cabíveis por diversas vezes. “A Vigilância em Saúde junto com a polícia já fez várias intervenções. Já notificamos o dono do imóvel e, por inúmeras vezes, aplicamos multas e ele não tomou as providências necessárias. Ele está ciente de que está em perímetro urbano e que não pode criar esses animais. Nesses 12 anos os suínos já foram retirados e ele volta com eles para o local. O caso corre agora na justiça e estamos aguardamos a ordem judicial para que seja feita uma ação conjunta entre Polícia Militar, Vigilância em Saúde e Ministério Público”, afirmou Adriana.

http://g1.globo.com/minas-gerais/triangulo-mineiro/noticia/2012/05/casa-vira-deposito-de-lixo-e-e-motivo-de-briga-entre-irmaos-em-divinopolis-mg.html

Stomach Acid Drugs Increase Risk of Bacterial Infections, FDA Warns

The Food and Drug Administration is warning consumers today that certain stomach acid drugs may increase the risk of a serious intestinal bacteria infection.

The drugs, including Nexium, Prilosec, Prevacid, Zegerid and others, fall into a category called proton pump inhibitors (PPIs). They are prescribed to treat acid reflux, stomach ulcers and other conditions, and work by reducing the amount of acid in the stomach.

The bacterial illness is called Clostridium difficile–associated diarrhea (CDAD), and its main symptom is diarrhea that does not improve, according to an FDA statement. The bacteria are commonly referred to as "C. diff."

"Stomach acid is a very important defense mechanism against pathogens. It kills them," said Dr. Edith R. Lederman, who authored a study published in October linking C. diff infections to stomach acid drugs, in an interview with MyHealthNewsDaily at the time.

Brain Training Games www.lumosity.com
Improve memory with scientifically designed brain exercises.
FDHS FL Digestive Health www.fdhs.com
Florida Digestive Health Specialist Board Certified Gastroenterologists
New Cancer Treatment www.nextgenerationpdt.com
Alternative, promising cancer treatment using PDT Therapy
Ads by Google

Patients taking PPIs who develop diarrhea that does not improve may have CDAD, according to the FDA. The agency is working with manufacturers to include information in the drug labels about the increased risk with use of PPIs. PPIs are the third highest-selling class of drugs in the U.S., according to 2010 findings from Consumer Reports.

Lederman's study, published in the journal Clinical Infectious Diseases, showed nearly half of 485 patients hospitalized at a medical center over a four-year period who had C. difficile infections had previously been prescribed an acid suppressing drug, most of which were either proton-pump inhibitors (PPIs), such as Prilosec and Prevacid, or histamine-2 antagonists, such as Tagamet and Zantac.

The FDA is also reviewing the risk of CDAD in users of histamine H2 receptor blockers.

The elderly, and people with certain medical problems, generally have the greatest chance of developing C. diff infections, according to the Centers for Disease Control and Prevention. The infection can spread in hospitals because C. diff spores can live outside the human body for a very long time, and may be found on items such as bed linens, bed rails, bathroom fixtures and medical equipment.

There are antibiotics that can be used to treat C. diff, according to the CDC, but in some severe cases, surgery to remove the infected part of the intestines may be needed.

In Lederman's study, 23 patients died from their C. diff infections; 19 of them had taken prescription acid suppressants during the 90 days before their hospital stay.

Hand washing, alcohol-based sanitizers, and taking only antibiotics that are prescribed by a doctor can lower a person's risk of getting or spreading C. diff, according to the CDC.

http://www.livescience.com/18368-stomach-acid-drugs-increase-cdiff-bacterial-infections.html

Silodosin helps reduce chronic prostatitis in men

New findings show that treatment with a specific alpha blocker helps reduce symptoms and improve quality of life for men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

The alpha-blocker, known as silodosin, works by selectively relaxing the muscles in the bladder neck and prostate. The treatment is already approved in Canada, the United States, the EU and Japan to treat painful symptoms of another prostate gland condition, benign prostatic hyperplasia, commonly referred to as an enlarged prostate.

Despite being the most common form of prostatitis, CP/CPPS is the most misunderstood and difficult to treat because the symptoms are very similar to other conditions and requires a significant degree of testing and screening to identify.

"Antibiotics are commonly used as a treatment, but are not typically effective, probably because CP/CPPS does not seem to be caused by a bacterial infection," explains lead researcher Curtis Nickel, a professor in the Department of Urology, practicing urologist at Kingston General Hospital, and Canada Research Chair in Urologic Pain and Inflammation.

CP/CPPS is a debilitating condition characterized by persistent discomfort in the lower pelvic area including the bladder area, testicles, and penis. Symptoms can be severe and include painful and frequent urination and difficult or painful ejaculation. The cause of the condition is unknown.

In Dr. Nickel's study, approximately 60 per cent of men reported feeling better after treatment with silodosin versus 30 per cent of participants who were given a placebo. The number of patients who reported feeling better is higher than in a similar study he ran several years ago that tested the effects of a different alpha blocker.

Source: Queen's University

http://www.news-medical.net/news/20110518/Silodosin-helps-reduce-chronic-prostatitis-in-men.aspx

Anemia Drug May Worsen Heart Attacks

TUESDAY, May 10 (HealthDay News) -- People given a drug known as erythropoietin alfa after a heart attack may experience new heart problems and even greater cardiac damage from the attack, a new study finds.

The drug, which stimulates red blood cells, has been used in some heart attack patients because certain studies suggested it might reduce the extent of heart attack damage and improve heart function, the researchers explained.

The study was published in the May 11 issue of the Journal of the American Medical Association.

"This study shows that erythropoietin should only be used with caution in patients with recent heart attacks," said Dr. Deepak L. Bhatt, chief of cardiology at the VA Boston Healthcare System, who was not involved in the study.

In fact, "there are hints in this study that the use of erythropoietin might have adverse cardiac effects," said Bhatt, who is also an associate professor of medicine at Harvard Medical School and the author of an accompanying editorial in the journal. This does not mean the drug doesn't have its place, for example, to help reduce transfusions in people with low blood counts, he added.

Known as erythropoiesis-stimulating agents (ESAs), erythropoietin drugs include Procrit and Epogen. They are typically used to treat anemia in cancer patients and to lower the risk of transfusions.

For the new study, dubbed the REVEAL trial, 222 heart attack patients in multiple centers across the United States were randomly assigned to receive erythropoietin alfa or a placebo after undergoing a balloon angioplasty or stent placement to open blocked heart vessels.

The patients had all suffered the most critical type of heart attack -- an ST segment elevation myocardial infarction, or STEMI. Because these patients are in danger of cardiac tissue death due to a local lack of oxygen (infarct) and other changes that increase the chance of heart failure and death, the researchers wanted to see whether erythropoietin alfa might have a protective effect.

The trial was led by Dr. Samer S. Najjar, of the Med-Star Health Research Institute at the Washington Hospital Center, in Washington, D.C. As a phase 2, randomized, double-blind trial involving a placebo and control group, in which neither the patients nor the researchers knew who was getting medication or the sham treatment, it is the type of study considered the gold standard of research.

The heart attack patients taking erythropoietin alfa received an intravenous dose of the medication four hours after a primary or rescue angioplasty or stent procedure; the control group received a saline infusion. Each patient underwent two cardiovascular magnetic resonance imaging scans, one before and one after treatment with erythropoietin alfa or the placebo.

The researchers found the size of the damaged area of the heart remained the same after each scan in both the erythropoietin alfa and placebo groups.

However, among patients 70 and older given erythropoietin alfa, heart damage actually increased over the first week after treatment, the researchers said.

Moreover, five patients receiving erythropoietin alfa either died, had another heart attack or had a blockage in the stent placed during angioplasty. None of the patients receiving placebo had these problems, the researchers said.

This is not the first time Procrit and other ESAs have been linked to serious adverse events. Last year, problems with ESAs prompted the U.S. Food and Drug Administration to require tighter guidelines on them for cancer patients because of the increased risk of stroke, heart failure, tumor promotion and death seen among those taking them.

Commenting on the study, Dr. Gregg Fonarow, the associate chief of cardiology at UCLA's David Geffen School of Medicine, said that "there has been substantial interest in the development of cardioprotective agents which could be administered during acute myocardial infarction (heart attack)."

There has been a growing body of experimental data that suggests erythropoietin may have anti-inflammatory properties and other qualities that could protect the heart, but earlier studies evaluating the effects of erythropoietin have been small, with conflicting results, he added.

"These findings, together with prior studies, suggest that there are not clinically relevant cardioprotective effects with erythropoietin-stimulating agents in patients with acute myocardial infarction," Fonarow said.

SOURCES: Deepak L. Bhatt, M.D., M.P.H., chief of cardiology, VA Boston Healthcare System Director, Integrated Interventional Cardiovascular Program, Brigham and Women's Hospital & VA Boston Healthcare System, associate professor of medicine, Harvard Medical School, Boston; Gregg Fonarow, M.D., associate chief, cardiology, David Geffen School of Medicine, University of California, Los Angeles; May 11, 2011, Journal of the American Medical Association

HealthDay

http://www.nlm.nih.gov/medlineplus/news/fullstory_111912.html

Acetaminophen tied to blood cancers

NEW YORK (Reuters Health) - New research shows chronic users of acetaminophen, a top-selling painkiller known as Tylenol in the U.S. and paracetamol in Europe, are at slightly increased risk for blood cancers.

Yet the risk remains low, and it's still uncertain what role the drug plays.

The finding adds another twist to the complicated evidence linking cancer and painkillers, and hints acetaminophen might be different from the rest.

Earlier work has shown that aspirin use might lower the odds of dying from colon cancer but increase the risk of bleeding ulcers. The picture has been less clear for blood, or hematologic, cancers, however.

"Prior to this study there was very little evidence that aspirin reduces your risk of hematological cancers," said Emily White of the Fred Hutchinson Cancer Research Center in Seattle, who worked on the new research.

There were some suggestions that acetaminophen might increase the risk of the cancers, on the other hand, but those were based on individual cases of blood cancer.

Studies of individual patients aren't considered as strong as the new one, which tracked a large population of healthy people over time.

"We have the first prospective study," White told Reuters Health.

Still, she warned, there is no proof that acetaminophen causes cancer, and the new results need to be confirmed before they are used in any treatment decision.

Earlier work has linked acetaminophen to asthma and eczema as well, but scientists still don't agree on whether the drug is the actual culprit or just an innocent bystander.

The new study suffers from the same limitations, in that people who use lots of painkillers could be dealing with medical problems that set them up for cancer down the road.

The scientists followed nearly 65,000 older men and women in Washington State. At the outset, they asked the participants about their use of painkillers over the past ten years and made sure that no one had cancer (except skin cancer).

Over some six years on average, 577 people -- or less than one percent -- developed a cancer involving the blood cells. Examples of such cancers include lymphoma and myelodysplastic syndrome, or MDS.

More than nine percent of people who developed one of these cancers used high amounts of acetaminophen, compared to only five percent of those who didn't get sick.

After accounting for things like age, arthritis and a family history of certain blood cancers, chronic acetaminophen users had nearly twice the risk of developing the disease.

"A person who is age 50 or older has about a one-percent risk in ten years of getting one of these cancers," White said. "Our study suggests that if you use acetaminophen at least four times a week for at least four years, that would increase the risk to about two percent."

No other painkillers -- including aspirin and ibuprofen -- were tied to the risk of blood cancers.

Dr. Raymond DuBois, a cancer prevention expert at the University of Texas MD Anderson Cancer Center in Houston, said acetaminophen works very differently than other painkillers and so might be expected to have different effects on cancer.

Still, "It was quite surprising to see that acetaminophen use increased the risk of" blood cancers, DuBois, who was not involved in the study, told Reuters Health by email.

McNeil Consumer Healthcare, the Johnson & Johnson subsidiary that sells Tylenol, did not respond to requests for comment.

White said it is too soon to make any recommendations based on the new study, and that none of the painkillers is free of side effects.

"Long-term use of any over the counter drug might have adverse effects," she said. "You have to weigh the benefits against the risk of all the drugs."

SOURCE: http://bit.ly/l8aYI0 Journal of Clinical Oncology, May 9, 2011.

Reuters Health

http://www.nlm.nih.gov/medlineplus/news/fullstory_111878.html

Vegetarianism Linked to Reduced Cataract Risk

Vegetarians may have a reduced risk of developing age-related cataracts, according to a recent study.

Vegetarianism is a dietary practice that restricts or excludes the consumption of animal products. Various forms of vegetarianism exist. For example, lacto vegetarians do not consume meat or eggs but do consume dairy products, while vegans exclude all animal products from their diets, including dairy and eggs.

In a recent study, researchers in Britain evaluated the association between age-related cataracts and vegetarianism for 27,670 non-diabetic individuals over 40 years-old from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford) with data from the Hospital Episode Statistics in England and Scottish Morbidity Records.

The researchers found that there was a significant association between vegetarianism and reduced cataract risk. When compared to high meat eaters, there was a progressive decrease in risk of cataracts for moderate meat eaters, low meat eaters, fish eaters (individuals who ate fish but no meat), vegetarians and vegans with risk ratios of 0.96, 0.85, 0.79, 0.70 and 0.60, respectively.

Additional research is necessary to further evaluate this potential association.

For more information about vegetarianism, please visit Natural Standard's Health & Wellness database.

References

Appleby PN, Allen NE, Key TJ. Diet, vegetarianism, and cataract risk. Am J Clin Nutr. 2011 May;93(5):1128-35.

http://naturalstandard.com/news/news201105010.asp

Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds

You stand a better chance of survival if your heart stops beating while you're in an exercise facility than if you're in another type of indoor public place, a new study found.

Overall, 50 percent of cardiac arrest victims survived if the attack occurred in a public place where some sort of exercise was happening, whereas only 36 percent of those who experienced cardiac arrest in other indoor public places survived. Exercise facilities included places traditionally thought of, such as gyms and fitness clubs, as well as places considered alternative exercise venues, such as bowling alleys and dance studios.

"Survival from sudden cardiac arrest with prompt resuscitation can really be quite high at exercise facilities," said lead researcher Dr. Richard L. Page, a cardiac electrophysiologist and chairman of the Department of Medicine at the University of Wisconsin. "That relates to the fact that people are healthier, they're feeling fit enough to go exercise, and they had a higher likelihood of CPR."

"We shouldn't just be deploying [automated external defibrillators] at fitness clubs," Page said. "We ought to consider less traditional exercise facilities as having patients at risk who could benefit from prompt resuscitation."

Though it's often confused with heart attack, sudden cardiac arrest is actually a different phenomenon.

Heart attack is a "plumbing problem," Page said. A blockage in the vessels of the heart cuts off blood flow, and part of the heart muscle dies. In some cases, a cardiac arrest can also occur.

Sudden cardiac arrest, Page explained, is caused by a disruption in the heart's electrical system. "You're unconscious within seconds and you're dead in 10 minutes if you don't get CPR and a defibrillation," he said. "The chance of survival is only a couple percent if you can't get immediate attention."

The goal of defibrillation is to reset the heart so it will return to a normal rhythm.

In their research, Page and his colleagues studied where cardiac arrests occurred in the Seattle area -- in indoor public places only -- between 1996 and 2008. They found 960 cases, 150 of which occurred at exercise facilities.

In the exercise facilities, 90 percent of the victims were men, 77 percent got CPR, 16 percent were treated with an automatic defibrillator machine and 50 percent survived.

Elsewhere in indoor public places, 75 percent of victims were men, 55 percent got CPR, 7 percent were treated with an automatic defibrillator machine and 36 percent survived.

At the exercise facilities, researchers found that 16 percent of the cardiac arrest sufferers were playing basketball, 9 percent were dancing, 9 percent "working out," 8 percent were on a treadmill and 8 percent each were playing tennis, bowling, swimming or weight lifting.

Though exercise is good for you overall, it does raise the risk for cardiac arrest, said Page, former president of the Heart Rhythm Society.

When asked why bowling alleys have so many cases of cardiac arrest, considering that bowling isn't a high-impact form of exercise, Page said the answer might lie in the fitness of bowlers and the atmosphere at a bowling alley, where people may be drinking alcohol.

He suggested that automatic defibrillators, which are often required in certain public places, should be placed in bowling alley s and dance studios, too. The machines typically cost $2,000 to $3,000.

Dr. Byron K. Lee, director of the electrophysiology laboratories and clinics at the University of California, San Francisco, said that though the study was interesting, it did not say whether the various physical activities boosted the risk for cardiac arrest over "baseline." Nor, he said, did it provide enough information to confirm whether the risk is high enough to warrant defibrillators in those places.

The study was to be presented Thursday in San Francisco at an annual meeting of the Heart Rhythm Society. Experts note that research presented at meetings should be considered preliminary because it has not been subjected to the rigorous scrutiny given to research published in medical journals.

SOURCES: Richard L. Page, M.D., chairman, Department of Medicine, University of Wisconsin, Madison, Wis.; Byron K. Lee, M.D., associate professor, medicine, and director, electrophysiology laboratories and clinics, University of California, San Francisco; May 5, 2011, presentation, Heart Rhythm 2011, San Francisco

HealthDay

http://www.nlm.nih.gov/medlineplus/news/fullstory_111753.html